enzastaurin has been researched along with Marfan Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bachir, S; Bedja, D; Caulfield, MJ; Dietz, HC; Doyle, AJ; Doyle, JJ; Ehsan, H; Habashi, JP; Huso, D; Huso, N; Judge, DP; Lindsay, ME; Myers, L; Rusholme, B; Schoenhoff, F; Squires, O; Thomas, CJ; Van Eyk, JE; Whitworth, RE; Wilson, NK | 1 |
1 other study(ies) available for enzastaurin and Marfan Syndrome
Article | Year |
---|---|
A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome.
Topics: Adult; Animals; Antihypertensive Agents; Calcium Channel Blockers; Child; Child, Preschool; Disease Models, Animal; Humans; Hydralazine; Indoles; Longitudinal Studies; MAP Kinase Signaling System; Marfan Syndrome; Mice, Inbred C57BL; Protein Kinase C beta; Receptor, Angiotensin, Type 1; Survival Analysis; Treatment Outcome | 2015 |